Viraleze has been successful in the lab against every single variant that was tested
Viraleze has been in a first in human trial for safety and there has been no serious adverse effects
Viraleze has been tested in the lab for pre and post covid infections and has been found to reduce viral load
Starpharma has been selling Viraleze under license multiple tens of thousands or possibly hundreds of thousands of units in the global market for last 2 years and the anecdotal evidence for preventative and protection has been overwhelmingly positive
We will have the results shorly
Why is it taking so long. Who knows. We can only speculate. Maybe the data was brilliant and there was enough information to expand the results to indications for RSV, Influenza A&B etc etc
SPL Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)